The clinical features of MOGAD partly overlap with multiple sclerosis (MS) and aquaporin-4 antibody (AQP4-Ab) seropositive neuromyelitis optica spectrum disorders (NMOSD-AQP4); however, different immunopathogenetic mechanisms underlie the three diseases [3]. Here, AQP4 is linked to multiple sclerosis.